This element focuses on the safe and person-centred administration of medications commonly used in dementia care, including cognitive enhancers and drugs f
Topic Synopsis
This element focuses on the safe and person-centred administration of medications commonly used in dementia care, including cognitive enhancers and drugs for behavioural symptoms. It emphasises understanding the individual's needs, preferences, and capacity to consent, ensuring medication is used effectively while respecting dignity and rights. The practical application involves collaborative care planning, monitoring for adverse effects, and adapting approaches to support the person's wellbeing.
Key Concepts & Core Principles
- Person-Centred Care: Understanding Tom Kitwood's 'flower of personhood' and applying its principles to ensure care is tailored to the individual's unique history, preferences, and abilities, promoting their well-being and dignity.
- Types of Dementia: Differentiating between common forms like Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia, recognising their distinct characteristics and progression.
- Communication Strategies: Developing effective verbal and non-verbal communication techniques, including active listening, validation, and adapting language to support individuals with cognitive impairments.
- Understanding Behaviour as Communication: Interpreting 'challenging behaviours' as expressions of unmet needs, discomfort, or confusion, and developing strategies to identify triggers and respond supportively.
- Legal and Ethical Frameworks: Applying the Mental Capacity Act 2005 (MCA) and Deprivation of Liberty Safeguards (DoLS) to protect the rights, autonomy, and best interests of individuals who lack capacity to make specific decisions.
Exam Tips & Revision Strategies
- Always link medication use to the principles of person-centred care, showing how the individual's preferences and daily life are respected.
- Include specific examples from practice, such as using a dosette box for a person with mild impairment or crushing tablets only where licensed and appropriate.
- Refer to key legislation like the Mental Capacity Act 2005 and professional standards for medication administration to strengthen your responses.
- Always link medication use back to quality of life outcomes and the individual’s personal goals.
- Use case scenarios to demonstrate how you would assess capacity and involve the person in decisions.
- Reference key legislation and guidance, such as NICE guidelines and the Mental Capacity Act, to support your points.
- Show a balance between pharmacological and psychosocial approaches—highlight that medication is rarely the sole intervention.
- Be explicit about the role of the health and social care professional in monitoring and reporting, showing accountability.
Common Misconceptions & Mistakes to Avoid
- Assuming all dementia medications cure the condition, rather than managing symptoms or slowing progression.
- Overlooking the importance of non-pharmacological interventions as first-line approaches for behavioural symptoms.
- Failing to consider the individual's capacity and the need to assess it each time medication is offered.
- Confusing the roles of different medication classes, such as cholinesterase inhibitors versus NMDA antagonists.
- Assuming that all individuals with dementia automatically lack capacity to consent to treatment.
- Overlooking the importance of regular medication reviews to avoid polypharmacy or inappropriate prescribing.
Examiner Marking Points
- Award credit for demonstrating knowledge of common classes of dementia medications (e.g., cholinesterase inhibitors, NMDA antagonists) and their indications.
- Award credit for explaining how a person-centred approach involves tailoring medication schedules to the individual's routines, using aids, and obtaining valid consent.
- Award credit for describing strategies to minimise and manage potential side effects, and for outlining the role of the care worker in reporting concerns.
- Award credit for evidencing understanding of the legal and ethical frameworks governing medication administration, such as the Mental Capacity Act 2005.
- Accurate naming and description of at least two common dementia medications with their therapeutic action.
- Evidence of tailoring medication administration to the individual's routines, preferences, and cultural needs.
- Clear reference to the Mental Capacity Act 2005 and best interest decision-making processes.
- Demonstration of monitoring for side effects (e.g., gastrointestinal, bradycardia) and communicating concerns appropriately.